Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Willow Tree Capital Corporation sold approximately 67,131 shares of common stock in a private placement for an aggregate offering price of $1.1 million. The shares were sold at a price of $15.97 per share pursuant to subscription agreements with investors under Regulation D exemptions.
Principal Credit Real Estate Income Trust Capital Raise of $650K
Principal Credit Real Estate Income Trust sold 31,925.51 common shares for approximately $650,000 in a continuous private offering. The sale included Class F-S and Class F-I common shares to third-party investors under a Regulation D exemption.
Cottonwood Communities, Inc. issued and sold 284,186 shares of its Series A Convertible Preferred Stock in a private placement offering between October 27 and November 3, 2026. The company received aggregate proceeds of approximately $2.83 million at a purchase price of $10.00 per share. This sale is part of an ongoing private offering of up to $200 million in preferred stock to accredited investors.
Macquarie Infrastructure Fund Capital Raise of $950K
Macquarie Infrastructure Fund, L.P. sold unregistered Class I limited partnership units for aggregate consideration of approximately $0.95 million on October 1, 2026. The sale was part of a continuous private offering to accredited investors and qualified purchasers, with the broader MIF Program raising approximately $131.0 million during the same period.
Lyell Immunopharma entered into a securities purchase agreement to raise $80.0 million through a private placement of 7,428,040 shares of common stock. The shares were sold to institutional accredited investors at a price of $10.77 per share, with the company agreeing to file a resale registration statement within 30 days of closing.
HarbourVest Private Equity Secondaries Fund Capital Raise of $1.95M
HarbourVest Private Equity Secondaries Fund L.P. sold 159,793 Class I Units for aggregate consideration of approximately $1.9 million on October 1, 2026. The sale was part of a continuous private offering to accredited investors and qualified purchasers, with the unit price finalized at a Transactional NAV of $12.17 per unit.
reAlpha Tech Corp. announced the pricing of a $1.75 million best efforts public offering of 4,375,000 shares of common stock (including pre-funded warrants) at $0.40 per share. The company intends to use the net proceeds for working capital, general corporate purposes, and potential acquisitions or litigation settlements.
SPACCircle Acquisition Corp. consummated its initial public offering of 10,000,000 units at $10.00 per unit, generating $100 million in gross proceeds. Simultaneously, the company completed a private placement of 266,590 units to its sponsor, SPACCircle Sponsor LLC, for approximately $2.67 million. A total of $100.5 million was placed in a trust account to fund a future business combination.
Acadia Realty Trust filed a new automatic shelf registration statement and entered into an amendment to its existing at-the-market (ATM) equity offering program. The amendment reflects the new registration statement and adds Citizens JMP Securities, LLC as a sales agent and forward purchaser for the program, which has approximately $199.1 million in capacity remaining.
H2O America completed the issuance and sale of 7,475,000 equity units, including the full exercise of the underwriters' over-allotment option, at a stated amount of $50 per unit. Each unit consists of a stock purchase contract obligating the holder to buy common stock by November 2029 and a beneficial interest in 5.300% Remarketable Senior Notes due 2031. The offering raised approximately $373.75 million in gross proceeds to be used for general corporate purposes.
Liminatus Pharma entered into a subscription agreement with a non-U.S. investor for a private placement of 260,001 shares of common stock. The company raised gross proceeds of approximately $0.65 million at a price of $2.50 per share. The proceeds are intended for working capital and general corporate purposes.
Reed's, Inc. entered into a securities purchase agreement with its majority stockholder, D&D Source of Life Holding, Ltd., for a $10.0 million private placement of 17,421,602 shares of common stock. The proceeds will be used for working capital and to satisfy a $10.0 million equity contribution requirement under the company's senior secured loan agreement.
Fortress Net Lease REIT issued and sold 8,730,792 common shares across multiple classes for gross proceeds of approximately $93.9 million in an unregistered private placement. Additionally, the company declared monthly distributions for all share classes to shareholders of record as of October 30, 2026.
Macquarie Infrastructure Income Opportunities Fund Capital Raise of $17.6M
Macquarie Infrastructure Income Opportunities Fund sold 691,489.361 Class J common shares for $17.55 million in its October 2026 monthly closing. The shares were issued as part of a continuous private offering at a price of $25.38 per share, which was the Fund's NAV as of September 30, 2026.
Kairos Pharma, Ltd. entered into a third amendment to its existing equity line of credit (ELOC) purchase agreement with Helena Global Investment Opportunities I Ltd. The amendment extends the company's option to use the ELOC for an additional year until December 31, 2028, and follows previous amendments that adjusted the purchase price to 97% of VWAP and shortened the pricing period.
Bread Financial Holdings issued and sold 5,000,000 depositary shares, each representing a 1/40th interest in its new 9.375% Series C Non-Cumulative Perpetual Preferred Stock. The company also granted underwriters a 30-day option to purchase up to an additional 750,000 depositary shares. The issuance includes restrictions on junior stock dividends and repurchases if preferred dividends are not paid.
Kennedy Lewis Capital Company reported that it has raised approximately $780.5 million in total consideration through its continuous public offering and private placement as of October 1, 2026. The company also disclosed a net asset value (NAV) per share of $19.68 for Class I and Class D shares and $19.65 for Class S shares as of September 30, 2026.
AEON Biopharma entered into a warrant amendment to reduce the exercise price of its outstanding two-year milestone warrants from $0.3221 to $0.20 per share. Certain holders have agreed to exercise their warrants at this reduced price, which is expected to generate approximately $6.2 million in gross proceeds for the company. The warrants were triggered for accelerated expiration following FDA feedback on the company's ABP-450 biosimilar pathway and will expire on November 16, 2026.
Peraso Inc. completed a $4.0 million private placement with Nant Capital, LLC, issuing 3,271,355 shares of common stock and pre-funded warrants. The company also entered into a registration rights agreement requiring it to file a resale registration statement for the shares and warrant shares by November 27, 2026.
Aspen Neuroscience, Inc. completed its initial public offering (IPO) of 9,375,000 shares of common stock at a price of $15.00 per share. The offering generated gross proceeds of approximately $140.6 million. In connection with the closing, the company's amended and restated certificate of incorporation and bylaws became effective.
ISQ Open Infrastructure Co Capital Raise of $29.5M
ISQ Open Infrastructure Company LLC issued and sold unregistered shares across multiple classes for total aggregate net consideration of approximately $29.5 million. The shares were sold to investors for cash and issued to independent directors for services rendered. The company also reported its monthly Transactional Net Asset Value (NAV) per share as of September 30, 2026.
Third Point Private Capital Partners Capital Raise of $1.15M
Third Point Private Capital Partners sold 42,493 Class I common shares in an unregistered private placement for total consideration of $1.15 million. The offering was conducted in reliance on Section 4(a)(2) and Regulation D/S exemptions for accredited investors and non-U.S. persons. The fund also disclosed a Net Asset Value (NAV) per share of $27.06 as of September 30, 2026.
Benchmark 2026-V24 Mortgage Trust Capital Raise of $759M
Benchmark 2026-V24 Mortgage Trust entered into agreements to sell $682.4 million of publicly offered certificates and $76.9 million of privately offered certificates. The transaction is structured as a commercial mortgage-backed securities (CMBS) offering with a closing date expected on or about November 13, 2026.
Cottonwood Communities, Inc. issued and sold 201,123 shares of its Series 2025 Preferred Stock in a private placement offering between October 19 and November 1, 2026. The company received aggregate proceeds of approximately $2.01 million from the sale, which is part of a larger $150 million private offering launched in December 2024.
Macquarie Infrastructure Fund Capital Raise of $950K
Macquarie Infrastructure Fund, L.P. sold unregistered Class I limited partnership units for $0.95 million as part of its continuous private offering. The broader MIF Program, which includes the Fund and other Macquarie-managed vehicles, has raised approximately $1,191.7 million in aggregate cash consideration since October 2025.
Vertical Data Inc. announced it intends to issue shares of common stock in a private placement transaction for gross proceeds of approximately $4.2 million. The company also disclosed a non-binding term sheet for a GPU-as-a-Service arrangement with a cloud provider involving 16,000 NVIDIA GPUs with a potential contract value of $2.8 billion.
BHAV Acquisition Corp II (SPAC) consummated its initial public offering (IPO) of 10,000,000 units at $10.00 per unit, generating gross proceeds of $100 million. Each unit consists of one Class A ordinary share and one right to acquire one-fourth of a share upon completion of a business combination. The company granted underwriters a 45-day option to purchase up to an additional 1.5 million units to cover over-allotments.
Regen Biopharma entered into a $10 million equity line of credit with Coventry Enterprises, allowing the company to sell shares of common stock at a 20% discount to market prices over a 36-month term. Additionally, the company issued a $125,000 10% unsecured promissory note to Coventry, using a portion of the proceeds to satisfy $71,557 in existing convertible debt.
Aptevo Therapeutics filed a prospectus supplement to its existing at-the-market (ATM) offering agreement with Roth Capital Partners, allowing for the potential sale of up to $2.3 million in common stock. The company disclosed that it has already raised $11.8 million in gross proceeds through the sale of 303,157 shares under the program to date.
Porch Group and Porch Reciprocal Exchange entered into an at-the-market (ATM) distribution agreement with StoneX Financial Inc. to sell up to 15 million shares of common stock. The offering includes 10 million shares currently held by the Reciprocal to convert non-admitted assets into cash and 5 million new shares to be issued by the company for general corporate purposes.